Studies of cisplatin and hemoglobin interactions using nanospray mass spectrometry and liquid chromatography with inductively-coupled plasma mass spectrometry

Analyst

Volumn 128, Issue 6, 2003, Pages 629-634

  Mandal, Rupasri ^a   Teixeira, Christine ^a   Li, Xing Fang ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; HEME DERIVATIVE; HEMOGLOBIN; IRON 57; PLATINUM; PROTEIN SUBUNIT;

ALPHA CHAIN; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BETA CHAIN; COMPLEX FORMATION; DRUG BINDING; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN STRUCTURE; TANDEM MASS SPECTROMETRY;

EID: 0038121526     PISSN: 00032654     EISSN: None     Source Type: Journal    
DOI: 10.1039/b212797k     Document Type: Article

References (27)

1. C. C. Chao, J. Formosan Med. Assoc., 1996, 95, 893-900.
2. S. L. Kelley, A. Basu, B. A. Teicher, M. P. Hacker, D. H. Hamer and J. S. Lazo, Science, 1988, 241, 1813-1815.
3. P. A. Andrews, M. P. Murphy and S. B. Howell, Cancer Chemother. Pharmacol., 1987, 19, 149-154.
4. J. Koropatnick and J. Pearson, Somatic Cell Mol. Genet., 1990, 16, 529-537.
5. Y. Kondo, M. Satoh, N. Imura and M. Akimoto, Anticancer Res., 1992, 12, 2303-2307.
6. K. Kasahara, Y. Fujiwara, K. Nishio, T. Ohmori, Y. Sugimoto, K. Komiya, T. Matsuda and N. Saijo, Cancer Res., 1991, 51, 3237-3242.
7. P. Farnworth, B. Hillcoat and I. Roos, Cancer Chemother. Pharmacol., 1990, 25, 411-417.
8. A. Bakka, L. Endresen, A. B. Johnsen, P. D. Edminson and H. E. Rugstad, Toxicol. Appl. Pharmacol., 1981, 61, 215-226.
9. R. C. DeConti, B. R. Toftness, R. C. Lange and W. A. Creasey, Cancer Res., 1973, 33, 1310-1315.
10. J. J. Gullo, C. L. Litterst, P. J. Maguire, B. I. Sikic, D. F. Hoth and P. V. Woolley, Cancer Chemother. Pharmacol., 1980, 5, 21-26.
11. F. Kratz in Metal Complexes in Cancer Chemotherapy ed. B. K. Keppler, VCH, Weinheim, Germany, 1993, pp. 391-429.
12. J. L. Aull, H. H. Daron, M. E. Friedman and P. Melius in Metal Ions in Biological Systems, ed. H. Sigel, Marcel Dekker, Inc., New York, 1980, vol. 11, pp. 337-376.
13. J. G. Zhang and W. E. Lindup, Biochem. Pharmacol., 1994, 47, 1127-1135.
14. D. K. Rai, B. Landin, G. Alvelius and J. Griffiths, Anal. Chem., 2002, 74, 2097-2102.
15. F. Kutlar and T. H. Huisman, J. Chromatogr., 1993, 620, 183-1989.
16. A. Hayashi, Y. Wada, T. Matsuo, I. Katakuse and H. Matsuda, Acta Haematol., 1987, 78, 114-118.
17. O. N. Jense, P. Roepstorff, B. Rozynov, M. Horanyi, J. Szelenyi, S. R. Hollan, E. A. Aseeva and V. A. Spivak, Biol. Mass Spectrom., 1991, 20, 579-584.
18. D. K. Rai, G. Alvelius, B. Landin and W. J. Griffiths, Rapid Commun. Mass Spectrom., 2000, 14, 1184-1194.
19. B. J. Wild, B. N. Green, E. K. Cooper, M. R. A. Lalloz, S. Erten, A. D. Stephens and D. M. Layton, Blood Cells Mol. Dis., 2001, 27, 691-704.
20. A. M. Gallardo, J. A. Hernandez, J. M. Rovira, L. Fulvia, A. Bosch and M. C. Pastor, J. Mass Spectrom., 2001, 36, 943-949.
21. R. Mustonen, K. Hemiinki, P. Hietanen, S. Leppala and M. Takala, Arch. Toxicol., Suppl., 1989, 13, 262-264.
22. R. Mustonen, P. Hietanen, S. Leppala, M. Takala and K. Hemminki, Arch Toxicol., 1989, 63, 361-366.
23. S. W. Johnson, J. P. Stevenson and P. J. O'Dwyer, in Cancer: Principles and Practice of Oncology, ed. V. T. DeVita, Jr, S. Hellman and S. A. Rosenberg, 6th edn., 2001, section 4, pp. 376-388.
24. R. Mustonen, K. Hemminki, A. Alhonen, P. Hietanen and M. Kiilunen, IARC Sci. Publ., 1988, 89, 329-332.
25. H. Okamoto, N. Sajio, T. Shinkai, K. Eguchi, Y. Sasaki, T. Tamura, Y. Ohe, A. Kojima, H. Kunikane and A. Karato, Ann. Oncol., 1992, 3, 819-824.
26. G. Lammering, U. M. Carl, H. Pape and K. A. Hartmann, Strahlenther. Onkol., 1999, 175, 559-562.
27. N. Thatcher, E. S. De Campos, D. R. Bell, W. P. Steward, G. Varghese, R. Morant, J. F. Vansteenkiste, R. Rosso, S. B. Ewers, E. Sundal, E. Schatzmann and H. Stocker, Br. J. Cancer, 1999, 80, 396-402.